Your browser doesn't support javascript.
loading
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Subbiah, Vivek; Chawla, Sant P; Conley, Anthony P; Wilky, Breelyn A; Tolcher, Anthony; Lakhani, Nehal J; Berz, David; Andrianov, Vasily; Crago, William; Holcomb, Monica; Hussain, Abrahim; Veldstra, Carson; Kalabus, James; O'Neill, Brianne; Senne, Lane; Rowell, Emily; Heidt, Analeah B; Willis, Katelyn M; Eckelman, Brendan P.
  • Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Chawla SP; Sarcoma Oncology Research Center, Santa Monica, California.
  • Conley AP; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wilky BA; Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado.
  • Tolcher A; NEXT Oncology, San Antonio, Texas.
  • Lakhani NJ; START Midwest, Michigan.
  • Berz D; Valkyrie Clinical Trials, Los Angeles, California.
  • Andrianov V; Inhibrx, Inc, La Jolla, California.
  • Crago W; Inhibrx, Inc, La Jolla, California.
  • Holcomb M; Inhibrx, Inc, La Jolla, California.
  • Hussain A; Inhibrx, Inc, La Jolla, California.
  • Veldstra C; Inhibrx, Inc, La Jolla, California.
  • Kalabus J; Inhibrx, Inc, La Jolla, California.
  • O'Neill B; Inhibrx, Inc, La Jolla, California.
  • Senne L; Inhibrx, Inc, La Jolla, California.
  • Rowell E; Inhibrx, Inc, La Jolla, California.
  • Heidt AB; Inhibrx, Inc, La Jolla, California.
  • Willis KM; Inhibrx, Inc, La Jolla, California.
  • Eckelman BP; Inhibrx, Inc, La Jolla, California.
Clin Cancer Res ; 29(16): 2988-3003, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37265425
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Condrosarcoma / Receptores del Ligando Inductor de Apoptosis Relacionado con TNF Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Condrosarcoma / Receptores del Ligando Inductor de Apoptosis Relacionado con TNF Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article